On the heels of basic research on the venom of Gila monsters in the preceding decades,1 exenatide secured the first US FDA approval in the class on April 28, 2005.2 While the prominent GLP-1 brand names are household names today, the class was off to a relatively slow start at first five years passed before it reached blockbuster status (US$1 billion (770 million) in sales), and another five went by before the first formal approval of a GLP-1 drug indicated for obesity became a reality.3 Last year saw sales for the class cross $50 billion and, with another 40% in revenue growth in store for 2025, the GLP-1 segment of the pharmaceutical industry is firmly in the rapid growth phase of the market, per Investment Bank Consensus
On top of that, lipotropic injections can support weight loss by speeding up fat breakdown during metabolism
Ghareghani M, Reiter RJ, Zibara K, Farhadi N (2018) Latitude, vitamin D, melatonin, and gut microbiota act in concert to initiate multiple sclerosis: a new mechanistic pathway
A.TongW
Usually theyre harmless, but if theyre severe, persistent, or come with pain, fever, nausea, or weight loss, they could point to conditions like SIBO or H
